CTX611

Serial Number 99583006
630

Registration Progress

Application Filed
Jan 7, 2026
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

CTX611

Basic Information

Serial Number
99583006
Filing Date
January 7, 2026
Drawing Code
4

Status Summary

Current Status
Active
Status Code
630
Status Date
Jan 7, 2026
Application
Pending
Classes
005 042

Rights Holder

CRISPR Therapeutics AG

25
Address
Baarerstrasse 14
ZUG V8 6300
CH

Ownership History

CRISPR Therapeutics AG

Original Applicant
25
ZUG V8 CH

Legal Representation

Attorney
Tiffany D. Gehrke

Application History

2 events
Date Code Type Description Documents
Jan 7, 2026 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 7, 2026 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Cells for medical or clinical use in the field of gene therapy for the treatment of cardiovascular diseases and thromboembolic diseases and disorders; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular diseases and thromboembolic diseases and disorders in the field of gene therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular diseases and thromboembolic diseases and disorders in the field of gene therapy
Class 042
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of gene therapy

Classification

International Classes
005 042